Choose Site

In the News

3 Takeaways As FDA Dishes On Interchangeable Biosimilars, Law360

January 17, 2017

IP partner Christopher Betti, Ph.D. was quoted in a Law360 article on recent FDA guidance. Chris, along with other attorneys, talk about the FDA’s guidance on biosimilar interchangeability and its implications.

Read the full Law360 story >>